TABLE 2.
Fluoroquinolone growth inhibition of S. pneumoniae strain 7785 and drug-stimulated DNA cleavage efficiencies of DNA gyrase and topoisomerase IV
| Drug | MIC (μg/ml) for strain 7785 | CC25 (μM) for DNA breakagea
|
|
|---|---|---|---|
| Gyrase | Topoisomerase IV | ||
| Ciprofloxacin | 1–2 | 80 | 2.5 |
| Gemifloxacin | 0.06 | 5 | 0.1 |
CC25, concentration of drug that converts 25% of the substrate DNA to the linear form in the presence of gyrase or topoisomerase IV.